Nexien BioPharma, Inc.
NXEN
$0.0095
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 52.87% | -75.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 52.87% | -75.58% | |||
| Operating Income | -52.87% | 75.58% | |||
| Income Before Tax | -23.44% | 63.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.44% | 63.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.44% | 63.01% | |||
| EBIT | -52.87% | 75.58% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -20.00% | 61.54% | |||
| Normalized Basic EPS | 0.00% | 62.50% | |||
| EPS Diluted | -20.00% | 61.54% | |||
| Normalized Diluted EPS | 0.00% | 62.50% | |||
| Average Basic Shares Outstanding | 0.42% | 2.56% | |||
| Average Diluted Shares Outstanding | 0.42% | 2.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||